ArticleBMC chemistry2025
Preparation, characterization and in vitro evaluation of phosphate-doped bioactive glass nanoparticles as promising candidates for therapeutic applications.
Article in BMC chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This research focuses on synthesizing bioactive glass nanoparticles with different phosphate concentrations to evaluate their physicochemical characteristics and explore their biomedical potential. The nanoparticles were fabricated by melting a mixture of silica, calcium oxide, sodium oxide, and ammonium dihydrogen phosphate at 1450 °C, followed by ball milling to obtain the optimal particle size distribution. The study systematically investigated the effect of phosphate content on the nanoparticles' structural properties and bioactive performance. Advanced characterization methods; such as XRD, FTIR, DTA, and FE-SEM-EDX were used to examine structural stability and phosphate-induced surface alterations. In vitro assays revealed dose-dependent antioxidant, anti-diabetic, anti-Alzheimer's, anti-arthritic, and anti-inflammatory activities, with higher phosphate content enhancing bioactivity. Results demonstrated enhanced radical scavenging and enzyme inhibition in samples with higher phosphate levels. These findings suggest that phosphate-doped bioactive glass nanoparticles hold significant promise for therapeutic applications. The research advances the understanding of how synthesis parameters influence bioactivity, providing valuable insights for designing next-generation biomedical materials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.